Advertisement
OtherEndocrine and Diabetes

Initial pharmacological characterization of a major hydroxy metabolite of PF-5190457: inverse agonist activity of PF-6870961 at the ghrelin receptor

Sara L. Deschaine, Morten A. Hedegaard, Claire L. Pince, Mehdi Farokhnia, Jacob E Moose, Ingrid A Stock, Sravani Adusumalli, Fatemeh Akhlaghi, James L. Hougland, Agnieszka Sulima, Kenner C. Rice, George F. Koob, Leandro Vendruscolo, Birgitte Holst and Lorenzo Leggio
Journal of Pharmacology and Experimental Therapeutics February 22, 2023, JPET-AR-2022-001393; DOI: https://doi.org/10.1124/jpet.122.001393
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherEndocrine and Diabetes

PF-5190457 metabolite activity at the ghrelin receptor

Sara L. Deschaine, Morten A. Hedegaard, Claire L. Pince, Mehdi Farokhnia, Jacob E Moose, Ingrid A Stock, Sravani Adusumalli, Fatemeh Akhlaghi, James L. Hougland, Agnieszka Sulima, Kenner C. Rice, George F. Koob, Leandro Vendruscolo, Birgitte Holst and Lorenzo Leggio
Journal of Pharmacology and Experimental Therapeutics February 22, 2023, JPET-AR-2022-001393; DOI: https://doi.org/10.1124/jpet.122.001393
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement